Prof., Skaggs Inst. For Chemical Biology, Scripps Research Inst.
Professor, University of Michigan
Partner, ARCH Venture Partners
Assoc. Prof., Dept. of Cell Biology, Scripps Research Institute
Founder, Avalon Ventures
President and Founder at Co-Flow Investing
Distinguished Lecturer, Sloan School of Management at MIT
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say | Luke Timmerman | 08/26/09 | Seattle | |
| FDA OKs Risperdal Consta for Bipolar | Luke Timmerman | 05/18/09 | Boston | |
| Alkermes Knocks on Door of Biotech Big Leagues, Aims to Make Drugs of its Own | Luke Timmerman | 02/12/09 | Boston | |
| TheraGenetics Bought by Avacta | Luke Timmerman | 01/29/09 | Boston | |
| Omeros Grabs $3.1M | Luke Timmerman | 01/28/09 | Seattle | |
| Fidelity Biosciences Pumps $65M into EnVivo Pharma | Luke Timmerman | 10/31/08 | Boston | |
| Page 2 of 2 | « previous page | |||